Proteins in the blood could warn people of cancer more than seven years before it is diagnosed

In De­cem­ber the FDA hit In­dia-based Tor­rent Phar­ma­ceu­ti­cals, Lau­rus Syn­the­sis and Dr. Red­dy’s Lab­o­ra­to­ries each with Form 483 let­ters pub­lished on Dec. 28. This was

Mark Cuban’s Cost Plus Drug Com­pa­ny is bring­ing an­oth­er brand-name type 2 di­a­betes treat­ment un­der its wing. Ther­a­cos­Bio’s re­cent­ly ap­proved SGLT2 in­hibitor Bren­zavvy is now